CEO of RxER Communications Corp, Anne Arvizu has been named co-chair of the 2019 Medical Affairs In Rare Disease Forum.
"It's an honor to support the biotech and pharma industry in this pivotal event. The agenda is superb and contains everything you need to focus on your patients and execute against the many objectives across Medical Affairs. As an expert in organizational design, I can add so much value to those working in precision medicine and it will be exciting to have the interaction and meeting of the minds specific to rare disease and precision medicine. Patients with rare life-debilitating diseased are globally widely under diagnose or untreated. Patient advocacy, patient access and other medical affairs operational tactics, such as targeted publications plans are game changers for patients that can go undiagnosed for years and even decades. I look forward to presenting, chairing and hearing the other experts in the room raise the bar for patients and the entire industry standard", says Dr. Arvizu.
This forum is presented by Dynamic Global Events and ACMA.
For more information visit: